Syros Pharmaceuticals, Inc. (SYRS) CEO Nancy Simonian on Q1 2022 Results - Earnings Call Transcript
Syros Pharmaceuticals, Inc. (SYRS) CEO Nancy Simonian on Q1 2022 Results - Earnings Call Transcript
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
-
NRx Pharmaceuticals, Inc. (NRXP) CEO Robert Besthof on Q1 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q1 2022 Results - Earnings Call Transcript
SeekingAlpha
-
AcelRx Pharmaceuticals, Inc. (ACRX) CEO Vincent Angotti on Q1 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Opiant Pharmaceuticals, Inc. (OPNT) CEO Dr. Roger Crystal on Q1 2022 Results - Earnings Call Transcript
SeekingAlpha
Advertisement
More coverage
-
Salarius Pharmaceuticals, Inc. (SLRX) CEO David Arthur on Q1 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Eledon Pharmaceuticals, Inc's (ELDN) CEO David-Alexandre Gros on Q1 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Marinus Pharmaceuticals, Inc. (MRNS) CEO Scott Braunstein on Q1 2022 Results - Earnings Call Transcript
SeekingAlpha
-
NovaBay Pharmaceuticals, Inc. (NBY) CEO Justin Hall on Q1 2022 Results - Earnings Call Transcript
SeekingAlpha